The BC Bud Corporation (BCBC.CN)
CAD 0.04
(33.33%)
CAD 0.04
(33.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.19 Million CAD | -11.64% |
| 2022 | -1.39 Million CAD | -34.58% |
| 2021 | -2.83 Million CAD | -369.06% |
| 2020 | -169.71 Thousand CAD | 41.98% |
| 2019 | -292.49 Thousand CAD | 42.4% |
| 2018 | -507.85 Thousand CAD | 0.95% |
| 2017 | -515.5 Thousand CAD | -128.5% |
| 2016 | -225.94 Thousand CAD | 51.89% |
| 2015 | -466.99 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 27.15 Thousand CAD | 105.24% |
| 2024 Q2 | -389.72 Thousand CAD | -1535.3% |
| 2023 Q3 | -347.82 Thousand CAD | -87.89% |
| 2023 Q2 | -185.12 Thousand CAD | -28.35% |
| 2023 Q4 | -518.25 Thousand CAD | -49.0% |
| 2023 Q1 | -144.23 Thousand CAD | 25.42% |
| 2022 Q4 | -193.38 Thousand CAD | -14.69% |
| 2022 FY | - CAD | -34.58% |
| 2022 Q3 | -168.61 Thousand CAD | 19.28% |
| 2022 Q2 | -208.88 Thousand CAD | 58.29% |
| 2022 Q1 | -500.85 Thousand CAD | 80.59% |
| 2021 Q1 | -30.06 Thousand CAD | -273.2% |
| 2021 Q4 | -2.58 Million CAD | -1800.99% |
| 2021 FY | - CAD | -369.06% |
| 2021 Q3 | -135.74 Thousand CAD | -137.33% |
| 2021 Q2 | -57.19 Thousand CAD | -90.23% |
| 2020 Q2 | -6901.00 CAD | -1504.88% |
| 2020 FY | - CAD | 41.98% |
| 2020 Q3 | -30.84 Thousand CAD | -346.89% |
| 2020 Q4 | 17.36 Thousand CAD | 156.29% |
| 2020 Q1 | -430.00 CAD | 0.0% |
| 2019 FY | - CAD | 42.4% |
| 2018 FY | - CAD | 0.95% |
| 2017 FY | - CAD | -128.5% |
| 2016 FY | - CAD | 51.89% |
| 2015 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 80.308% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 40.511% |
| Blueberries Medical Corp. | -1.22 Million CAD | 2.11% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 81.556% |
| CordovaCann Corp. | -1.6 Million CAD | 25.371% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 54.411% |
| Captor Capital Corp. | 2.42 Million CAD | 149.398% |
| City View Green Holdings Inc. | -2.01 Million CAD | 40.629% |
| 1CM Inc. | 1.31 Million CAD | 191.054% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -4723.999% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 45.842% |
| IM Cannabis Corp. | -2.79 Million CAD | 57.132% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 72.832% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -204.938% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 62.543% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 204.766% |
| Ovation Science Inc. | -778.83 Thousand CAD | -53.565% |
| Pharmadrug Inc. | -1.33 Million CAD | 10.412% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 80.251% |
| RAMM Pharma Corp. | -6.3 Million CAD | 81.022% |
| RIV Capital Inc. | -20.28 Million CAD | 94.103% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 78.624% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 98.459% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 59.467% |
| 1933 Industries Inc. | -10.03 Million CAD | 88.079% |
| Red Light Holland Corp. | -5.25 Million CAD | 77.244% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -55.732% |
| Xebra Brands Ltd. | -1.49 Million CAD | 19.999% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 15.252% |